H-Drugs in the leading international journal again!
"Eat"
-
-
The US FDA approved a new treatment for non-small cell lung cancer - Tremelimumab + Durvalumab + platinum-based chemotherapy. The triple combination therapy significantly improves efficacy and patient survival and has a good safety profile.
-
When it comes to hemorrhoids, many people probably think of the fierce, unspeakable, restless pain
-
Medical
New Treatment For Childhood Brain Tumours, Tovorafenib, Shows Promising Results With An Efficiency Rate Of 91%!
According to data from a phase 2 trial, the new treatment Tovorafenib resulted in significant tumour shrinkage in 64% of patients with low-grade gliomas in children, a clinical benefit rate of 91%.
-
Damp-heat in the spleen and stomach is a common TCM condition, which simply means that the spleen and stomach are already bad, but are affected by external invasion or diet, resulting in poor digestion and damp-heat in the spleen and stomach.
-
Data from a study recently published by the Royal Marsden Cancer Centre showed promising data for the combination of Avutometinib + Defactinib in the treatment of ovarian cancer, resulting in significant tumour shrinkage in 28% of patients and disease control in 93% of patients.
-
Every disease has a cause, and we are all sick because of various factors. Understanding the causes of diseases can help us to prevent them, which will help our health a lot.
-
Prior to the granting of marketing authorisation by the MHRA, Biyze® had been approved by the European Commission for a number of indications and is currently the only drug approved for the treatment of MZL in Great Britain.
-
Chinese medicine is a special diet that is guided by the theories of Chinese medicine, culinary science and nutrition, in which Chinese medicine is combined with certain foods of medicinal value in a reasonable formula, or soup, or dish, or congee, or tea, with unique colour, aroma, taste, shape and effect, and has the effect of health care, disease prevention and cure.
-
Medical
Significant Improvement In Survival For Pancreatic Cancer Patients! A first-Line NALIRIFOX Regimen To Look Forward To!
As medicine continues to advance, there are many good drugs and options to fight cancer. Just recently, a study showed that the NALIRIFOX regimen significantly improved the overall survival of patients with advanced pancreatic ductal adenocarcinoma who had not received previous treatment.